CUPR (Cuprina Holdings (Cayman)) Market Cap: $11.32 Mil (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CUPR Cuprina Holdings (Cayman) Ltd CUPR
10 GF Score
Price $4.22
! 6 Warning Signs
View Full Analysis

What is Cuprina Holdings (Cayman) Market Cap?

Cuprina Holdings (Cayman) CUPR -2.51% 10 Market Cap is $11.32 Mil as of Jul. 14, 2026. GuruFocus rates CUPR with a GF Score™ of 10/100. The stock has 6 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Cuprina Holdings (Cayman) ranks worse than 83.95% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cuprina Holdings (Cayman)'s share price for the quarter that ended in Dec. 2025 was $3.2008. Cuprina Holdings (Cayman)'s Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 2.68 Mil. Therefore, Cuprina Holdings (Cayman)'s market cap for the quarter that ended in Dec. 2025 was $8.58 Mil.

Cuprina Holdings (Cayman)'s quarterly market cap increased from Dec. 2024 ($0.00 Mil) to Jun. 2025 ($125.69 Mil) but then declined from Jun. 2025 ($125.69 Mil) to Dec. 2025 ($8.58 Mil).

Cuprina Holdings (Cayman)'s annual market cap stayed the same from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then increased from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($8.58 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cuprina Holdings (Cayman)'s Enterprise Value for Today is $9.28 Mil.


Cuprina Holdings (Cayman)  (NAS:CUPR) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Cuprina Holdings (Cayman) Market Cap Related Terms


Cuprina Holdings (Cayman) Market Cap Historical Data

* Premium members only.

The historical data trend for Cuprina Holdings (Cayman)'s Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cuprina Holdings (Cayman) Market Cap Chart

Cuprina Holdings (Cayman) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
0.00 0.00 0.00 0.00 8.58

Cuprina Holdings (Cayman) Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Market Cap Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 125.69 8.58

CUPR vs BNGO, UEEC, FEMY: Market Cap Comparison

For the Medical Instruments & Supplies subindustry, Cuprina Holdings (Cayman)'s Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cuprina Holdings (Cayman) Market Cap vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cuprina Holdings (Cayman)'s Market Cap distribution charts can be found below:

* The bar in red indicates where Cuprina Holdings (Cayman)'s Market Cap falls into.


CUPR
10GF Score
Cuprina Holdings (Cayman) Ltd CUPR
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cuprina Holdings (Cayman) Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Cuprina Holdings (Cayman)'s Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=$3.2008*2.681
=$8.58

Cuprina Holdings (Cayman)'s Market Cap for the quarter that ended in Dec. 2025 is calculated as

Market Cap (Q: Dec. 2025 )=Share Price (Q: Dec. 2025 )*Shares Outstanding (EOP) (Q: Dec. 2025 )
=$3.2008*2.681
=$8.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $11.32 Mil mean?
Cuprina Holdings (Cayman) (CUPR) has a Market Cap of $11.32 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cuprina Holdings (Cayman) and its competitors. According to the industry distribution chart, Cuprina Holdings (Cayman) ranks #727 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 83.9%.
Is Cuprina Holdings (Cayman)'s Market Cap too high?
Cuprina Holdings (Cayman)'s current Market Cap is $11.32 Mil. The Medical Devices & Instruments industry median Market Cap is 116.94. Cuprina Holdings (Cayman)'s value of $11.32 Mil is 90.3% below this industry median. Based on the distribution chart, Cuprina Holdings (Cayman) ranks #727 out of 866 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cuprina Holdings (Cayman) has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Cuprina Holdings (Cayman)'s Market Cap compare to BNGO and UEEC?
According to the Medical Devices & Instruments industry distribution chart, Cuprina Holdings (Cayman) ranks #727 out of 866 companies for Market Cap. This places Cuprina Holdings (Cayman) in the lower half of its industry. The industry median Market Cap is 116.94. Cuprina Holdings (Cayman)'s value of $11.32 Mil is 90.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 116.94, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cuprina Holdings (Cayman)'s current Market Cap of $11.32 Mil is 90.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cuprina Holdings (Cayman) and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 116.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cuprina Holdings (Cayman)'s current Market Cap is $11.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cuprina Holdings (Cayman) stock overvalued right now?
Cuprina Holdings (Cayman) (CUPR) has a current Market Cap of $11.32 Mil. The current Market Cap is $11.32 Mil and 90.3% below the Medical Devices & Instruments industry median of 116.94. Cuprina Holdings (Cayman)'s overall GF Score™ is 10/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cuprina Holdings (Cayman) (CUPR), the current Market Cap is $11.32 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cuprina Holdings (Cayman) Business Description

Address c/o Blk 1090 Lower Delta Road No. 06-08, Singapore, SGP, 169201
Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.
10GF Score

Get the complete analysis for CUPR

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.22
Price